# Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)

> **NCT00552110** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 707 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** OXY combination: mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY)
- **DRUG:** OXY combination: mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY)
- **DRUG:** mometasone furoate nasal spray (MFNS) once daily
- **DRUG:** oxymetazoline nasal spray (OXY) twice daily
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00552110
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 707 (ACTUAL)
- **Last updated:** 2024-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00552110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00552110, "Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00552110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*